Accustem Sciences Inc.

OTC : ACUT

AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing products for the treatment and management of various cancers. Its primary product candidate is StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company was founded in 2013 and is headquartered in New York, New York.

Information

Website
https://accustem.com
Sector
Healthcare
Industry
Biotechnology
Type
Common Stock
Country
United States

Price

USD 0.39

Symbol

ACUT

Type

Common Stock

Previous Close

 :

0.43

52 Week Range

 :

0.27 - 0.99

Volume

 :

70.00

Average Volume

 :

1,278.00

High

 :

0.39

Low

 :

0.39

Change

 :

-0.04

Percent change (%)

 :

-9.30

Stakeville

A Free-to-Play Trading Game. Sharpen your skills, trade stocks, and have fun!

Play Now
Getting Started
Get Your Free Account For Educational Purpose Knowledgebase
Legal
Cookie Policy Privacy Policy Terms & Conditions
Customer Service
Help Desk Support Stakeville Newsletter
Stay Connected
Contact Us Official Blog About Us
Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...